当前位置:首页 - 行情中心 - 卫光生物(002880) - 财务分析 - 现金流量表

卫光生物

(002880)

  

流通市值:58.42亿  总市值:58.42亿
流通股本:2.27亿   总股本:2.27亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金170,052,177.141,221,649,170.7814,401,293.52537,973,211.97
  收到的税费返还202,734.896,499,372.96,053,471.465,092,280.01
  收到其他与经营活动有关的现金854,522.8852,564,822.6122,213,009.425,860,354.36
  经营活动现金流入小计171,109,434.911,280,713,366.21842,667,774.4548,925,846.34
  购买商品、接受劳务支付的现金123,608,844.03573,845,362.75415,014,230.45269,211,889.52
  支付给职工以及为职工支付的现金98,927,538.31261,125,187.6191,630,783.26145,646,351.04
  支付的各项税费45,479,561.32113,672,710.8991,362,801.7161,386,436.16
  支付其他与经营活动有关的现金20,684,518.5968,888,241.2153,539,557.6933,089,795.58
  经营活动现金流出小计288,700,462.251,017,531,502.45751,547,373.11509,334,472.3
  经营活动产生的现金流量净额-117,591,027.34263,181,863.7691,120,401.2939,591,374.04
二、投资活动产生的现金流量:
  取得投资收益收到的现金68,424.6714,731,111.1114,731,111.1114,657,611.11
  处置固定资产、无形资产和其他长期资产收回的现金净额-37,844.423,6503,650
  收到的其他与投资活动有关的现金60,000,000150,000,000150,000,000140,000,000
  投资活动现金流入小计60,068,424.67164,768,955.53164,734,761.11154,661,261.11
  购建固定资产、无形资产和其他长期资产支付的现金24,940,447.27169,689,898.91139,923,297.6957,679,440.57
  投资支付的现金16,500,000---
  支付其他与投资活动有关的现金200,000,000250,000,000250,000,000250,000,000
  投资活动现金流出小计241,440,447.27419,689,898.91389,923,297.69307,679,440.57
  投资活动产生的现金流量净额-181,372,022.6-254,920,943.38-225,188,536.58-153,018,179.46
三、筹资活动产生的现金流量:
  取得借款收到的现金150,888,770.39421,314,597.72131,067,909.27104,710,324.84
  收到其他与筹资活动有关的现金-182,550,413.48--
  筹资活动现金流入小计150,888,770.39603,865,011.2131,067,909.27104,710,324.84
  偿还债务支付的现金140,860,359450,501,362.2129,308,020118,947,661
  分配股利、利润或偿付利息支付的现金3,927,276.6465,727,025.4561,909,163.210,490,308.98
  支付其他与筹资活动有关的现金327,442.51,642,615945,945623,700
  筹资活动现金流出小计145,115,078.14517,871,002.65192,163,128.2130,061,669.98
  筹资活动产生的现金流量净额5,773,692.2585,994,008.55-61,095,218.93-25,351,345.14
五、现金及现金等价物净增加额-293,189,357.6994,254,928.93-195,163,354.22-138,778,150.56
  加:期初现金及现金等价物余额368,985,365.99274,730,437.06274,730,437.06274,730,437.06
  期末现金及现金等价物余额75,796,008.3368,985,365.9979,567,082.84135,952,286.5
补充资料:
  净利润-245,791,094.36-107,575,098.85
  资产减值准备-25,044,059.98-13,543,662.61
  固定资产和投资性房地产折旧-145,028,262.85-64,781,868.86
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-145,028,262.85-64,781,868.86
  无形资产摊销-8,359,850.4-4,379,441.48
  长期待摊费用摊销-4,896,237.3-2,780,149.58
  处置固定资产、无形资产和其他长期资产的损失---0
  固定资产报废损失-36,763.95--8,339
  公允价值变动损失--1,870,660.37--
  财务费用-21,674,813.77-9,965,736.16
  投资损失--4,760,170.05--2,022,539.02
  递延所得税--13,502,726.48--528,961.47
  其中:递延所得税资产减少--12,749,314.87--109,663.7
    递延所得税负债增加--753,411.61--419,297.77
  存货的减少--92,874,389.64--104,695,134.7
  经营性应收项目的减少--330,438,589.46-12,381,101.21
  经营性应付项目的增加-239,446,813.57--69,191,738.2
  其他-15,234,931.86--
  现金的期末余额-368,985,365.99-135,952,286.5
  减:现金的期初余额-274,730,437.06-274,730,437.06
  现金及现金等价物的净增加额-94,254,928.93--138,778,150.56
公告日期2026-04-272026-04-272025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑